Arca
Skip to content
Tools
Tools

ACL AcuStar

System, Multipurpose For In Vitro Coagulation Studies. 510(k) K170314, from Instrumentation Laboratory CO (Bedford, MA). Product code JPA, class 2.

As of Nov 18, 2026, K170314 is an FDA 510(k) held by Instrumentation Laboratory CO, substantially equivalent on Mar 3, 2017 after 30 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Mar 3, 2017
  • Review time: 30 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

Automated immunoassay analyzer designed specifically for in vitro diagnostic use in a clinical laboratory. The assay analysis is based on chemiluminescent technology. The system provides results for both direct measurements and calculated parameters.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other JPA Clearances

The newest 510(k)s for the same product code; their median review was 158 days; see every JPA device

Record

Type
Special
Received
Feb 1, 2017
Review panel
Hematology
Regulation
21 CFR 864.5425

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.